Takeda faces challenging outlook as patent woes loom
This article was originally published in Scrip
Executive Summary
Takeda saw solid profit gains in the fiscal year to 31 March on the absence of one-off costs related to its acquisition of Millennium. But stripping these out revealed underlying weakness, and the Japanese company is expecting a challenging few years as patents for its top product begin to expire.